Results 61 to 70 of about 627 (150)

Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes

open access: yesEuropean Journal of Clinical Investigation, Volume 56, Issue 6, June 2026.
In 1969, consecutive patients undergoing CMR, MAD was assessed in end‐diastole and end‐systole across 2‐, 3‐, and 4‐chamber views (panels A–F, lower left), and native T1 relaxation times were measured at the mitral annulus (upper left, T1 colour map).
Katharina Mascherbauer   +21 more
wiley   +1 more source

Mitral annular disjunction

open access: yesCirculation: Cardiovascular Imaging, 2021
Joachim Feger   +2 more
openaire   +3 more sources

Disappearance of electrocardiographic abnormalities associated with the arrhythmic pattern of a Barlow disease after surgical mitral valve repair

open access: yesClinics and Practice, 2017
We describe the case of a 46-year old female with a Barlow’s disease (MVP) characterized by systolic curling of posterior left ventricular (LV) wall + significant mitral annular disjunction + complex ventricular arrhythmias + syncope + inverted T waves ...
Matteo Augello, Luca Lanzarini
doaj   +1 more source

Cardiac MRI Across ESC Guidance in the Last Decade

open access: yesClinical Cardiology, Volume 49, Issue 5, May 2026.
CMR: bridging clinical challenges to guideline solutions. Four panels summarise the role of cardiovascular magnetic resonance (CMR) in ESC guidance. Abbreviations: CMR = cardiovascular magnetic resonance. ESC = European Society of Cardiology. MINOCA = myocardial infarction with non‐obstructive coronary arteries. RV = right ventricle.
Alexander Gall   +6 more
wiley   +1 more source

Mitral Annular Disjunction: A Contrary View [PDF]

open access: yesJournal of the American Society of Echocardiography, 2022
Dimosthenis, Pandis   +2 more
openaire   +2 more sources

The added value of three-dimensional transthoracic echocardiography in mitral annular disjunction: a case report

open access: yesFrontiers in Cardiovascular Medicine
BackgroundMitral annular disjunction (MAD) refers to the arrhythmic mitral valve prolapse (MVP) syndrome associated with ventricular arrhythmias and sudden cardiac death. Although the pathophysiology of this disease is still under investigation, specific
Konstantinos Papadopoulos   +2 more
doaj   +1 more source

Bachmann's Bundle‐Related Atrial Tachycardias Following Catheter Ablation of Persistent Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, Volume 37, Issue 3, Page 561-571, March 2026.
ABSTRACT Background Atrial tachycardias (AT) after radiofrequency ablation (RFA) of atrial fibrillation (AF) may utilize Bachmann's bundle (BB). Due to their epicardial location, these ATs remain poorly understood. Objective To describe the electrophysiologic and anatomic basis of BB‐related ATs.
Nate Christian‐Miller   +10 more
wiley   +1 more source

Mitral annular disjunction and ventricular arrhythmia: A rare arrhythmic syndrome

open access: yesAnnales Academiae Medicae Silesiensis
Mitral annular disjunction (MAD) is a structural anomaly of the heart characterized by the displacement of the posterior mitral leaflet’s attachment toward the left atrial wall.
Alicja Pawlus   +2 more
doaj   +1 more source

Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse

open access: yesJournal of Cardiovascular Magnetic Resonance, 2021
Objectives We aimed to evaluate the relationship between mitral annular disjunction (MAD) severity and myocardial interstitial fibrosis at the left ventricular (LV) base in patients with mitral valve prolapse (MVP), and to assess the association between ...
Anna Giulia Pavon   +10 more
doaj   +1 more source

A Review of Nanoparticle‐Based Astrocyte Modulation in CNS Disorders: Evaluating the Underexplored Potential of Intranasal Delivery

open access: yesNano Select, Volume 7, Issue 1, January 2026.
Nanoparticle‐driven nose‐to‐brain drug delivery offers a noninvasive approach to bypass the blood–brain barrier (BBB) and directly modulate reactive astrocytes in CNS disorders. This review highlights biodegradable nanoparticles for astrocyte modulation, enhancing drug bioavailability, sustained release, and neuroinflammation control.
Senamile M. Dlamini   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy